{
"info": {
"nct_id": "NCT00357448",
"official_title": "Phase I Dose Escalation Study of Intraperitoneal (I.P.) ONTAK® Administered to Patients With Advanced Stage Ovarian Cancer",
"inclusion_criteria": "* Patients with a histologic diagnosis of epithelial ovarian carcinoma, primary peritoneal carcinoma, or epithelial fallopian tube carcinoma\n* Patients with the following histologic epithelial cell types are eligible: Serous adenocarcinoma, endometrioid adenocarcinoma, mucinous adenocarcinoma, undifferentiated carcinoma, clear cell adenocarcinoma, transitional cell carcinoma, and mixed epithelial carcinoma\n* Patients with advanced stage refractory ovarian carcinoma: patients unable to achieve first complete remission (CR) with first or second line chemotherapy OR patients with disease relapse after achieving second CR\n* Patients must be 30 days out from last chemotherapy; previous chemotherapy must include a platinumbased regimen and paclitaxel (Taxol)\n* Patients must have undergone primary debulking surgery\n* Patients must have a peritoneal catheter suitable for I.P. infusion\n* White blood cell count (WBC) > 3.0 THOU/ul\n* Serum creatinine =< 2.5 mg/dL\n* ALT =< 2.5 x upper limit of normal\n* AST =< 2.5 x upper limit of normal\n* Total bilirubin =< 2.0 x upper limit of normal\n* Albumin >= 3.0 g/dL\n* Subjects must have a Performance Status Score (Zubrod/SWOG Scale) =< 2\n* Subjects must have recovered from major infections and/or surgical procedures and, in the opinion of the investigator, not have a significant active concurrent medical illness precluding protocol treatment\n* Lymphocytes > 1.0 THOU/ul\n* Platelets >= 100 THOU/ul\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Prior treatment with ONTAK (DAB389IL-2) or DAB486IL-2\n* Known history of hypersensitivity to diphtheria toxin or IL-2\n* Moderate (symptomatic requiring the use of diuretics) or severe (symptomatic requiring paracentesis or other invasive intervention) ascites\n* Active autoimmune disease\n* Known history of pulmonary disease except controlled asthma\n* Known history significant cardiac disease\n* Concurrent malignancy requiring active treatment\n* Clinical or radiological evidence of acute bowel obstruction within 30 days of enrollment",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Patients with a histologic diagnosis of epithelial ovarian carcinoma, primary peritoneal carcinoma, or epithelial fallopian tube carcinoma",
"criterions": [
{
"exact_snippets": "histologic diagnosis of epithelial ovarian carcinoma",
"criterion": "epithelial ovarian carcinoma",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "histologic diagnosis of ... primary peritoneal carcinoma",
"criterion": "primary peritoneal carcinoma",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
},
{
"exact_snippets": "histologic diagnosis of ... epithelial fallopian tube carcinoma",
"criterion": "epithelial fallopian tube carcinoma",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients with the following histologic epithelial cell types are eligible: Serous adenocarcinoma, endometrioid adenocarcinoma, mucinous adenocarcinoma, undifferentiated carcinoma, clear cell adenocarcinoma, transitional cell carcinoma, and mixed epithelial carcinoma",
"criterions": [
{
"exact_snippets": "histologic epithelial cell types ... Serous adenocarcinoma",
"criterion": "histologic epithelial cell type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "Serous adenocarcinoma"
}
]
},
{
"exact_snippets": "histologic epithelial cell types ... endometrioid adenocarcinoma",
"criterion": "histologic epithelial cell type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "endometrioid adenocarcinoma"
}
]
},
{
"exact_snippets": "histologic epithelial cell types ... mucinous adenocarcinoma",
"criterion": "histologic epithelial cell type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "mucinous adenocarcinoma"
}
]
},
{
"exact_snippets": "histologic epithelial cell types ... undifferentiated carcinoma",
"criterion": "histologic epithelial cell type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "undifferentiated carcinoma"
}
]
},
{
"exact_snippets": "histologic epithelial cell types ... clear cell adenocarcinoma",
"criterion": "histologic epithelial cell type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "clear cell adenocarcinoma"
}
]
},
{
"exact_snippets": "histologic epithelial cell types ... transitional cell carcinoma",
"criterion": "histologic epithelial cell type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "transitional cell carcinoma"
}
]
},
{
"exact_snippets": "histologic epithelial cell types ... mixed epithelial carcinoma",
"criterion": "histologic epithelial cell type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "mixed epithelial carcinoma"
}
]
}
]
},
{
"line": "* Patients with advanced stage refractory ovarian carcinoma: patients unable to achieve first complete remission (CR) with first or second line chemotherapy OR patients with disease relapse after achieving second CR",
"criterions": [
{
"exact_snippets": "advanced stage refractory ovarian carcinoma",
"criterion": "ovarian carcinoma",
"requirements": [
{
"requirement_type": "stage",
"expected_value": "advanced"
},
{
"requirement_type": "refractory",
"expected_value": true
}
]
},
{
"exact_snippets": "unable to achieve first complete remission (CR) with first or second line chemotherapy",
"criterion": "complete remission (CR)",
"requirements": [
{
"requirement_type": "achievement",
"expected_value": false
},
{
"requirement_type": "chemotherapy line",
"expected_value": [
"first",
"second"
]
}
]
},
{
"exact_snippets": "disease relapse after achieving second CR",
"criterion": "disease relapse",
"requirements": [
{
"requirement_type": "after achieving",
"expected_value": "second CR"
}
]
}
]
},
{
"line": "* Patients must be 30 days out from last chemotherapy; previous chemotherapy must include a platinumbased regimen and paclitaxel (Taxol)",
"criterions": [
{
"exact_snippets": "Patients must be 30 days out from last chemotherapy",
"criterion": "time since last chemotherapy",
"requirements": [
{
"requirement_type": "time since",
"expected_value": {
"operator": ">=",
"value": 30,
"unit": "days"
}
}
]
},
{
"exact_snippets": "previous chemotherapy must include a platinumbased regimen",
"criterion": "previous chemotherapy regimen",
"requirements": [
{
"requirement_type": "inclusion",
"expected_value": "platinumbased regimen"
}
]
},
{
"exact_snippets": "previous chemotherapy must include ... paclitaxel (Taxol)",
"criterion": "previous chemotherapy regimen",
"requirements": [
{
"requirement_type": "inclusion",
"expected_value": "paclitaxel (Taxol)"
}
]
}
]
},
{
"line": "* Patients must have undergone primary debulking surgery",
"criterions": [
{
"exact_snippets": "Patients must have undergone primary debulking surgery",
"criterion": "primary debulking surgery",
"requirements": [
{
"requirement_type": "completion",
"expected_value": true
}
]
}
]
},
{
"line": "* Patients must have a peritoneal catheter suitable for I.P. infusion",
"criterions": [
{
"exact_snippets": "peritoneal catheter suitable for I.P. infusion",
"criterion": "peritoneal catheter",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": "I.P. infusion"
}
]
}
]
},
{
"line": "* White blood cell count (WBC) > 3.0 THOU/ul",
"criterions": [
{
"exact_snippets": "White blood cell count (WBC) > 3.0 THOU/ul",
"criterion": "white blood cell count (WBC)",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">",
"value": 3.0,
"unit": "THOU/ul"
}
}
]
}
]
},
{
"line": "* Serum creatinine =< 2.5 mg/dL",
"criterions": [
{
"exact_snippets": "Serum creatinine =< 2.5 mg/dL",
"criterion": "serum creatinine",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "mg/dL"
}
}
]
}
]
},
{
"line": "* ALT =< 2.5 x upper limit of normal",
"criterions": [
{
"exact_snippets": "ALT =< 2.5 x upper limit of normal",
"criterion": "ALT",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "x upper limit of normal"
}
}
]
}
]
},
{
"line": "* AST =< 2.5 x upper limit of normal",
"criterions": [
{
"exact_snippets": "AST =< 2.5 x upper limit of normal",
"criterion": "AST",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.5,
"unit": "x upper limit of normal"
}
}
]
}
]
},
{
"line": "* Total bilirubin =< 2.0 x upper limit of normal",
"criterions": [
{
"exact_snippets": "Total bilirubin =< 2.0 x upper limit of normal",
"criterion": "total bilirubin",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": "<=",
"value": 2.0,
"unit": "x upper limit of normal"
}
}
]
}
]
},
{
"line": "* Albumin >= 3.0 g/dL",
"criterions": [
{
"exact_snippets": "Albumin >= 3.0 g/dL",
"criterion": "albumin level",
"requirements": [
{
"requirement_type": "level",
"expected_value": {
"operator": ">=",
"value": 3.0,
"unit": "g/dL"
}
}
]
}
]
},
{
"line": "* Subjects must have a Performance Status Score (Zubrod/SWOG Scale) =< 2",
"criterions": [
{
"exact_snippets": "Performance Status Score (Zubrod/SWOG Scale) =< 2",
"criterion": "Performance Status Score",
"requirements": [
{
"requirement_type": "scale",
"expected_value": "Zubrod/SWOG Scale"
},
{
"requirement_type": "value",
"expected_value": {
"operator": "<=",
"value": 2,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Subjects must have recovered from major infections and/or surgical procedures and, in the opinion of the investigator, not have a significant active concurrent medical illness precluding protocol treatment",
"criterions": [
{
"exact_snippets": "recovered from major infections",
"criterion": "major infections",
"requirements": [
{
"requirement_type": "recovery",
"expected_value": true
}
]
},
{
"exact_snippets": "recovered from ... surgical procedures",
"criterion": "surgical procedures",
"requirements": [
{
"requirement_type": "recovery",
"expected_value": true
}
]
},
{
"exact_snippets": "not have a significant active concurrent medical illness",
"criterion": "active concurrent medical illness",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* Lymphocytes > 1.0 THOU/ul",
"criterions": [
{
"exact_snippets": "Lymphocytes > 1.0 THOU/ul",
"criterion": "lymphocytes",
"requirements": [
{
"requirement_type": "count",
"expected_value": {
"operator": ">",
"value": 1.0,
"unit": "THOU/ul"
}
}
]
}
]
},
{
"line": "* Platelets >= 100 THOU/ul",
"criterions": [
{
"exact_snippets": "Platelets >= 100 THOU/ul",
"criterion": "platelet count",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 100,
"unit": "THOU/ul"
}
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Prior treatment with ONTAK (DAB389IL-2) or DAB486IL-2",
"criterions": [
{
"exact_snippets": "Prior treatment with ONTAK (DAB389IL-2)",
"criterion": "prior treatment with ONTAK (DAB389IL-2)",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Prior treatment with ... DAB486IL-2",
"criterion": "prior treatment with DAB486IL-2",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Known history of hypersensitivity to diphtheria toxin or IL-2",
"criterions": [
{
"exact_snippets": "Known history of hypersensitivity to diphtheria toxin",
"criterion": "hypersensitivity to diphtheria toxin",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Known history of hypersensitivity to ... IL-2",
"criterion": "hypersensitivity to IL-2",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Moderate (symptomatic requiring the use of diuretics) or severe (symptomatic requiring paracentesis or other invasive intervention) ascites",
"criterions": [
{
"exact_snippets": "Moderate (symptomatic requiring the use of diuretics) ... ascites",
"criterion": "ascites",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "moderate"
},
{
"requirement_type": "symptomatic",
"expected_value": true
},
{
"requirement_type": "treatment",
"expected_value": "use of diuretics"
}
]
},
{
"exact_snippets": "severe (symptomatic requiring paracentesis or other invasive intervention) ascites",
"criterion": "ascites",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "symptomatic",
"expected_value": true
},
{
"requirement_type": "treatment",
"expected_value": [
"paracentesis",
"other invasive intervention"
]
}
]
}
]
},
{
"line": "* Active autoimmune disease",
"criterions": [
{
"exact_snippets": "Active autoimmune disease",
"criterion": "autoimmune disease",
"requirements": [
{
"requirement_type": "activity",
"expected_value": "active"
}
]
}
]
},
{
"line": "* Known history of pulmonary disease except controlled asthma",
"criterions": [
{
"exact_snippets": "Known history of pulmonary disease",
"criterion": "pulmonary disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
}
]
},
{
"exact_snippets": "except controlled asthma",
"criterion": "controlled asthma",
"requirements": [
{
"requirement_type": "control status",
"expected_value": "controlled"
}
]
}
]
},
{
"line": "* Known history significant cardiac disease",
"criterions": [
{
"exact_snippets": "Known history significant cardiac disease",
"criterion": "cardiac disease",
"requirements": [
{
"requirement_type": "history",
"expected_value": true
},
{
"requirement_type": "severity",
"expected_value": "significant"
}
]
}
]
},
{
"line": "* Concurrent malignancy requiring active treatment",
"criterions": [
{
"exact_snippets": "Concurrent malignancy requiring active treatment",
"criterion": "concurrent malignancy",
"requirements": [
{
"requirement_type": "treatment status",
"expected_value": "active treatment"
}
]
}
]
},
{
"line": "* Clinical or radiological evidence of acute bowel obstruction within 30 days of enrollment",
"criterions": [
{
"exact_snippets": "Clinical or radiological evidence of acute bowel obstruction",
"criterion": "acute bowel obstruction",
"requirements": [
{
"requirement_type": "evidence",
"expected_value": [
"clinical",
"radiological"
]
}
]
},
{
"exact_snippets": "within 30 days of enrollment",
"criterion": "time since acute bowel obstruction",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": {
"operator": "<=",
"value": 30,
"unit": "days"
}
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}